Corona Remedies made a remarkable debut on the stock market, opening with a significant premium. The company’s Rs 655-crore IPO was massively oversubscribed, attracting strong interest from institutional and retail investors alike. This robust demand reflects confidence in Corona Remedies’ solid financial performance, strategic focus on key healthcare areas, and promising earnings potential.
Related Posts
Will Joe Burrow play against the Jacksonville Jaguars tomorrow?
Cincinnati Bengals’ quarterback Joe Burrow is set to play against the Jacksonville Jaguars at Paycor Stadium. After a victorious season opener against the Cleveland Browns, […]
In first foreign trip after Sindoor, PM likely to highlight Pak’s terror export
Following an invitation from Canadian PM Mark Carney, PM Modi has accepted to attend the G7 summit in Alberta. This decision comes after speculation about […]
EC orders ‘Special Revision’ of Assam voter list, final roll in Feb; how it differs from SIR
The Election Commission has ordered a Special Revision of Assam’s electoral rolls, with January 1, 2026, as the qualifying date and the final list due […]